![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/28 | |
A61K 35/17 | |||
C07K 19/00 | |||
A61K 39/395 | |||
A61P 35/00 |
(11) | Number of the document | 3283520 |
(13) | Kind of document | T |
(96) | European patent application number | 16714020.1 |
Date of filing the European patent application | 2016-03-30 | |
(97) | Date of publication of the European application | 2018-02-21 |
(45) | Date of publication and mention of the grant of the patent | 2020-05-06 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2016/051808 |
Date | 2016-03-30 |
(87) | Number | WO 2016/166630 |
Date | 2016-10-20 |
(30) | Number | Date | Country code |
201562146825 P | 2015-04-13 | US | |
201662286473 P | 2016-01-25 | US | |
201662301177 P | 2016-02-29 | US |
(72) |
KUO, Tracy Chia-Chien, US
CHAPARRO RIGGERS, Javier Fernando, US
SASU, Barbra Johnson, US
GALETTO, Roman, FR
BOLDAJIPOUR, Bijan Andre, US
SOMMER, Cesar Adolfo, US
VAN BLARCOM, Thomas John, US
PERTEL, Thomas Charles, US
RAJPAL, Arvind, US
DUCHATEAU, Philippe, FR
JUILLERAT, Alexandre, FR
VALTON, Julien, FR
|
(73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
(54) | CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN |
CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN |